BCDA BioCardia, Inc.: institutional ownership and insider trading
22 funds reported holding $1.82M of BioCardia, Inc. in their latest 13F filings; in Q2 2026 funds net bought $800K, with 6 new positions and 5 funds selling out; over the last 12 months insiders bought $170K and sold $0 on the open market.
Famous investors holding BCDA
- Ken Griffin (Citadel Advisors): $28.5K, 0.0% of the portfolio
Largest institutional holders of BCDA
- CITIGROUP INC (C, C-PN) — $493K
- CM Management, LLC — $372K
- VANGUARD GROUP INC — $169K
- VANGUARD CAPITAL MANAGEMENT LLC — $154K
- Pingora Partners LLC — $149K
- UBS Group AG (UBS) — $96.2K
- GEODE CAPITAL MANAGEMENT, LLC — $82.7K
- VANGUARD FIDUCIARY TRUST CO — $82.2K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $48.1K
- BROWN ADVISORY INC — $44.1K
Recent BCDA insider trades
- Oct 16, 2026: Altman Peter bought 500 shares ($475)
- Sep 29, 2026: Altman Peter bought 1,000 shares ($1.03K)
- Sep 23, 2026: Altman Peter bought 1,900 shares ($2.00K)
- Sep 3, 2026: Altman Peter bought 800 shares ($872)
5%+ owners
- Thomas A. Satterfield, Jr.: 9.9% (Schedule 13G/A, filed Aug 13, 2025)
- Lincoln Alternative Strategies LLC: 7.5% (Schedule 13G, filed Sep 19, 2025)
- Blank Andrew Scott: 5.5% (Schedule 13D, filed May 22, 2025)
- Daly Joseph Patrick: 0.0% (Schedule 13D/A, filed May 21, 2025)